ORGO: Organogenesis Holdings Inc. Class A Common Stock Company Profile & Statistics

About

Organogenesis is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the Advanced Wound Care and Surgical & Sports Medicine markets.

Info & Links

CEO

Gary S. Gillheeney

Headquarters

85 Dan Road
Canton, MA 02021, UNITED STATES

Auditor

RSM US LLP

Share holders

607

Employees

862

Organogenesis Holdings Inc. Class A Common Stock Statistics

Valuation Measures

Market Capitalization²

658.24M

Enterprise Value

627.59M

Enterprise Value/EBITDA(ttm)

50.15

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.93

Price to Book(mrq)

1.61

Price to Cash(ytd)

15.72

Profitability

Gross Margin(ttm)

75.93%

Operating Margin(ttm)

-1.62%

Profit Margin(ttm)

0.09%

Return on Equity(ttm)

-2.69%

Return on Invested Capital(ttm)

0.68%

Return on Assets(ttm)

-1.63%

Income Statement

Revenue(ttm)

455.04M

Revenue Per Share(ttm)

3.43

Gross Profit(ttm)

342.58M

EBITDA(ttm)³

12.51M

Net Income Available to Common(ttm)

-7.38M

Diluted EPS(ttm)

-0.06

Share Statistics

Beta (5Y Monthly)

1.77

52-Week Change

64.70%

S&P 500 52-Week Change

12.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

132.58M

Dividend Yield

0.00%

Float⁴

79.33M

% Held by Insiders

36.90%

% Held by Institutions

49.57%

Balance Sheet

Total Cash(mrq)

94.93M

Total Cash Per Share(mrq)

0.72

Total Debt(mrq)

64.28M

Total Debt/Equity(mrq)

0.72%

Current Ratio(mrq)

3.69%

Quick Ratio(mrq)

2.74%

Book Value Per Share(mrq)

2.09

Cash Flow

Operating Cash Flow Per Share(ytd)

0.11

Free Cash Flow(ytd)

4.18M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

ORGO

Organogenesis Holdings Inc. Class A Common Stock

Organogenesis Holdings Inc. Class A Common Stock Profile